Revelation Biosciences REVB
NASDAQ REVB
$3.67 +0.07 (+1.94%)
As of: Oct 22, 2026 · 9:30 AM EDT

Revelation Biosciences (REVB) Long-Term Debt Issuances (2020 - 2022)

Updated

Revelation Biosciences (REVB) posted Long-Term Debt Issuances of $2.5 million for FY2022, up 233.3% from $750,000 in FY2021.

Analysis

Revelation Biosciences (REVB) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends

Since FY2019, Revelation Biosciences has reported Long-Term Debt Issuances for 4 years.

  • Annual Long-Term Debt Issuances shows a three-year compound annual growth rate of 530.0% (FY2019 to FY2022).
  • Business Quant data shows REVB's Long-Term Debt Issuances at $750,000 in FY2021 (+400.0%), $150,000 in FY2020 and $10,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn -
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn -
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn -
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn -
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Revelation Biosciences 14.05 Mn -34.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 2.50 Mn
Sep 30, 2020 71,960.00
Jun 30, 2020 28,040.00
Mar 31, 2020 50,000.00
API Access

Revelation Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=REVB&period=max&api_key=YOUR_API_KEY